awmsg logo



dexamfetamine sulfate


Reference No. 2342

Publication date:
27/02/2014


Appraisal information

dexamfetamine sulfate 1 mg/ml oral solution


Company: Martindale Pharma
BNF category: Central nervous system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 26/02/2014

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, dexamfetamine sulfate cannot be endorsed for use within NHS Wales for the treatment of narcolepsy and children with refractory hyperkinetic states under the supervision of a physician specialising in child psychiatry.
Statement of Advice (SOA)
Download